http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007126782-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6dd0dbd192f5dccbed5600872d5f4201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51b903d17ad7c39627a64155b7b449f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d829c494f5741501a98043b6d781a173
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_108e557a1e079b5781d8f98ae0e9cc88
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1087
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1031
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21K1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
filingDate 2007-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_689c6eaa1000d9030f90853c9b8829b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d6e162d315b3cd5a7b60e0e486acc7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c502b8e7774df8032c880ab3d8798a0
publicationDate 2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007126782-A2
titleOfInvention Hadron treatment planning with adequate biological weighting
abstract Treatment planning methods are provided that determine the variability of relative biological effectiveness (RBE) along a beam line and calculate, among other things, what intensity of hadron beam such as a proton or a carbon ion beam should be applied to achieve a desired biological dose at treatment site of a patient afflicted with a medical condition. Typically, three or four RBE values at three or four corresponding spacially- dispersed intervals along the beam line are calculated. In one embodiment, two RBE values for the spread-out Bragg peak (SOBP) region of the treatment site; one for the proximal section and one for the declining distal section is calculated. A third and different RBE value may be determined for the distal edge region of the SOBP. A fourth value may also be calculated for a pre-SOBP region.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3682945-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009160308-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020152660-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10180505-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113677396-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10610700-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485994-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009160309-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9274067-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426606-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8822958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9880301-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9878180-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3020451-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113677396-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9084887-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018091427-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9207193-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2708261-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012524565-A
priorityDate 2006-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006145088-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7268358-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297

Total number of triples: 48.